Column Group IV-A, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 409,140 shares at $4.84 ($2.0M) on 2023-01-10, disclosed to the SEC on 2023-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.84 | 100,070 | $484K | 24.7% |
| 2 | $4.84 | 100,070 | $484K | 24.7% |
| 3 | $4.76 | 209,000 | $995K | 50.7% |
| Total | $4.80 avg | 409,140 | $2.0M | 100% |
| Filing → |
| RAPT | BUY | 2022-05-12 | $26.7M | — | Filing → |